Novo Nordisk to free up capacity by changing injection pen in US
Novo Nordisk intends to eventually replace the injection pen used for Wegovy in the US, according to Finans. The reason is that it could free up capacity at Novo Nordisk’s filling factories.
Novo Nordisk launched Wegovy in the US in a disposable pen with a single dose, while in the rest of the world Wegovy is sold in Novo Nordisk’s Flextouch pen with room for four doses or a month’s supply.
When the time is right, Novo Nordisk intends to roll out the Flextouch pen in the US as well, says Henrik Wulff, the Executive Vice President responsible for Novo Nordisk’s production.
Leading up to the 2021 launch, however, US authorities and patients preferred Novo Nordisk’s disposable pen because it’s easy and simple to use.
”So that was the starting point for the launch. That said, in a few years we will do what we can to overcome that hurdle,” says Wulff.
English edit: Catherine Brett
